Regeneron Pharmaceuticals (REGN) Deferred Taxes (2013 - 2026)
Regeneron Pharmaceuticals' quarterly Deferred Taxes came in at $96.0 million in Q1 2026, down 30.98% year-on-year from $139.1 million in Q1 2025, and down 58.71% quarter-over-quarter from $232.5 million in Q4 2025.
Regeneron Pharmaceuticals has reported Deferred Taxes for 14 years, with the latest figure at $96.0 million in Q1 2026.
- For the quarter ending Q1 2026, Deferred Taxes fell 30.98% year-over-year to $96.0 million; the trailing twelve-month figure through Mar 2026 stood at $742.3 million (up 5.14% YoY), and the FY2025 full-year result was $785.4 million, up 3.71% from the prior year.
- Deferred Taxes for Q1 2026 stood at $96.0 million, down from $232.5 million in the prior quarter.
- The five-year high for Deferred Taxes was $286.3 million in Q4 2023, with the low at $85.7 million in Q3 2022.
- Average Deferred Taxes over 5 years is $189.6 million, with a median of $190.4 million recorded in 2024.
- Year-over-year, Deferred Taxes jumped 2327.72% in 2022 and tumbled 43.57% in 2024.
- Tracing REGN's Deferred Taxes over 5 years: stood at $279.7 million in 2022, then grew by 2.36% to $286.3 million in 2023, then decreased by 2.13% to $280.2 million in 2024, then fell by 17.02% to $232.5 million in 2025, then tumbled by 58.71% to $96.0 million in 2026.
- The last three Deferred Taxes figures came in at $96.0 million (Q1 2026), $232.5 million (Q4 2025), and $278.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 96.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96.00 Mn |
| Dec 31, 2025 | 232.50 Mn |
| Sep 30, 2025 | 278.60 Mn |
| Jun 30, 2025 | 135.20 Mn |
| Mar 31, 2025 | 139.10 Mn |
| Dec 31, 2024 | 280.20 Mn |
| Sep 30, 2024 | 168.60 Mn |
| Jun 30, 2024 | 118.10 Mn |
| Mar 31, 2024 | 190.40 Mn |
| Dec 31, 2023 | 286.30 Mn |
| Sep 30, 2023 | 125.70 Mn |
| Jun 30, 2023 | 209.30 Mn |
| Mar 31, 2023 | 216.50 Mn |
| Dec 31, 2022 | 279.70 Mn |
| Sep 30, 2022 | 85.70 Mn |
| Jun 30, 2022 | 156.00 Mn |
| Mar 31, 2022 | 225.00 Mn |
| Dec 31, 2021 | 205.90 Mn |
| Sep 30, 2021 | -7.00 Mn |
| Jun 30, 2021 | -41.70 Mn |
| Mar 31, 2021 | -10.10 Mn |
| Dec 31, 2020 | 42.30 Mn |
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | -108.10 Mn |
| Mar 31, 2020 | -9.90 Mn |
| Dec 31, 2019 | 20.60 Mn |
| Sep 30, 2019 | -15.30 Mn |
| Jun 30, 2019 | 114.60 Mn |
| Mar 31, 2019 | 10.70 Mn |
| Dec 31, 2018 | 106.50 Mn |
| Sep 30, 2018 | 18.00 Mn |
| Jun 30, 2018 | 9.10 Mn |
| Mar 31, 2018 | 6.40 Mn |
| Dec 31, 2017 | -427.04 Mn |
| Sep 30, 2017 | 50.51 Mn |
| Jun 30, 2017 | 16.75 Mn |
| Mar 31, 2017 | 40.99 Mn |
| Dec 31, 2016 | 169.77 Mn |
| Sep 30, 2016 | 27.68 Mn |
| Jun 30, 2016 | 82.87 Mn |
| Mar 31, 2016 | 79.79 Mn |
| Dec 31, 2015 | 55.65 Mn |
| Sep 30, 2015 | 6.91 Mn |
| Jun 30, 2015 | 21.81 Mn |
| Mar 31, 2015 | 37.26 Mn |
| Dec 31, 2014 | 19.12 Mn |
| Sep 30, 2014 | 15.07 Mn |
| Jun 30, 2014 | 13.33 Mn |
| Mar 31, 2014 | 5.76 Mn |
| Dec 31, 2013 | -145.09 Mn |
| Sep 30, 2013 | -9.63 Mn |
| Jun 30, 2013 | 53.00 Mn |
| Mar 31, 2013 | 39.53 Mn |